Citi raised the firm’s price target on GE HealthCare (GEHC) to $110 from $103 and keeps a Buy rating on the shares. Operating margins expanded “significantly” in Q4, driving EPS ahead of consensus, while total company organic orders increased 6% year-over-year and the book-to-bill ratio increased, reflecting continued product demand, the analyst tells investors. 2025 guidance “seems conservative,” the analyst added in a post-earnings note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Cisco jumps after earnings beat, Trump teases reciprocal tariffs: Morning Buzz
- Strong Buy Recommendation for GE Healthcare Technologies Inc. Amid Promising Financial Performance and Growth Prospects
- GE HealthCare price target raised to $103 from $99 at BTIG
- Early notable gainers among liquid option names on February 13th
- Morning Movers: Molson Coors rises following earnings, Deere falls